CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 4,595 shares at an average $14.64 ($67,293)
- 4 Open-market sale Chief Financial Officer sold 1,395 shares at $14.09 ($19,656)
- 4 Open-market sale CHIEF DEVELOPMENT OFFICER sold 4,943 shares at $14.09 ($69,647)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 3,519 shares at an average $14.27 ($50,200)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 5,514 shares at an average $14.20 ($78,310)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 4,223 shares at an average $14.24 ($60,120)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 2,118 shares at an average $14.16 ($30,000)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 12,130 shares at an average $14.26 ($172,952)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 5,393 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 6,250 shares (grant or award)
- 4 Grant or award Director acquired 8,800 shares (grant or award)
- 144 Insider Sale of Securities
Page 9 of 33 · 660 filings